Permascand signs a Master Supply Agreement with major U.S. based client

Permascand has signed a Master Supply Agreement with one of the largest global players in the chlorine and caustic soda market to deliver electrodes and electrochemical cells for the client’s chloralkali and diaphragm technology. The estimated value of the agreement is in the range of SEK 30-50 million per year for a period of three years.

Within the business segment Industrial Solutions, Permascand is committed to develop electrochemical solutions for industries to increase the efficiency of its client’s production. The client that Permascand now has entered into a Master Supply Agreement with, is a global leading manufacturer of chlorine, caustic soda, caustic potash (potassium hydroxide), calcium chloride, sodium chlorite and polyvinyl chloride resins. During 2020, approximately SEK 15 million of Permascands net sales were attributable to ad-hoc orders from the client (i.e., 3.6 percent).

“We are very pleased to continue this well-established business relationship with a major U.S. based client within chloralkali, diaphragm technology. Together we strive to reduce the impact of our environmental footprint by creating and bring innovative sustainable solutions to the industry market. This is according to our growth plan with focus on the North American market and contributes to the global green transition”, says Peter Lundström, CEO at Permascand.

The agreement is valid for three years and shall, unless terminated by a party, be renewed for two more years, a total of five years.

Permascand receives order of EUR 17.5 million from its largest client

Permascand has received an order from its largest client, one of the major global players in the ballast water treatment system (BWTS) arena, for the supply of ballast water disinfection cells, confirming a continued partnership and further cementing Permascands position as one of the world leaders in the provision of ballast water treatment cells. The order will be included as order intake for the third quarter of 2021 and is worth EUR 17,5 million, with planned deliveries beginning 2022.

The discharge of untreated ballast water from ships can have a negative impact on the marine environment and is now strictly governed through a number of globally enforceable regulations. Permascand’s electrochlorination cells used to treat ships ballast water and other water purification applications, play a key part of increased sustainability within the field by preventing the spread of invasive aquatic species.

“We are happy to receive this order and to continue this well-established partnership with one of our major clients, it is of great value and is aligned with the green transition and future growth. It represents yet another significant step towards becoming the leading independent global supplier of electrochemical solutions for clean tech applications in green technologies.”, says Peter Lundström CEO at Permascand.

During the 2020 financial year, 61 percent of Permascand’s net sales were attributable to orders from the client. The client was established by a team of experts with a strong background and solid knowledge in waste and water treatment technology for marine applications. Driven by the needs of shipowners and stricter environmental protection legislation, the company started designing and manufacturing innovative BWTS. Today, the company holds a strong position in the global market for BWTS.

Q2: Continued profitable growth during an intense first half-year

Interim report January-June 2021

Second quarter 2021 (Q2 2020)

  • Order intake decreased 27 percent, totaling SEK 41 million (57)
  • Sales increased 57 percent to SEK 123 million (78)
  • Operating loss totaled SEK -3 million (1), corresponding to -2 percent (1) of revenue
  • Adjusted operating profit totaled SEK 12 million (1)
  • Earnings after tax totaled SEK -5 million (-3)
  • Earnings per share before and after dilution amounted to SEK -0.1 (-0.06)
  • Cash flow from operating activities totaled SEK -39 million (10)

January-June 2021 (January-June 2020)

  • Order intake decreased 39 percent, totaling SEK 98 million (161)
  • Sales increased 7 percent to SEK 198 million (186)
  • Operating loss totaled SEK -6 million (17), corresponding to -3 percent (9) of revenue
  • Adjusted operating profit totaled SEK 14 million (17)
  • Earnings after tax totaled SEK -11 million (6)
  • Earnings per share before and after dilution amounted to SEK -0.21 (0.13)
  • Cash flow from operating activities totaled SEK -53 million (37)

Events during the second quarter of 2021

  • On April 1, 2021, Permascand announced a comprehensive innovation effort to conduct advanced research and development to enable large-scale and cost-effective production of green hydrogen for energy storage. In total, the company plans investments of around SEK 300 million over the next three years in a full-scale technology and innovation center and investments in the company’s research team.
  • On May 18, 2021, Permascand announced its intention to list the company’s shares on the Nasdaq First North Premier Growth Market. The offering and prospectus were published on May 27, 2021, and the first day of trading in Permascand’s shares took place on June 4, 2021.
  • On June 15, 2021, Permascand announced that the company had signed a letter of intent (LOI) with Verdagy for the joint development of a new electrochemical cell for the production of green hydrogen.

CEO comment: Continued profitable growth during an intense first half-year

We have now closed the books on an eventful first half of 2021, a period characterized with several new collaboration agreements, exciting customer projects and the listing on Nasdaq First North Premier Growth Market. After an intensive period during the listing process, we had the pleasure of ringing the listing bell on June 4, thereby welcoming over 2 300 new shareholders to Permascand. The listing is an important step in our continued journey of growth, in which we will continue to deliver profitable growth by capitalizing on rapidly growing markets being driven by megatrends in sustainability and the environment.

Customer demand has continued to recover from the waves of the pandemic that occurred in 2020 and early 2021, and is expected to increase as government authorities ease the restrictions linked to the pandemic. The order intake reflects the dynamic of the industry and decreased as expected, by 27 percent to SEK 41 million. Sales during the second quarter of 2021 increased by 57 percent to SEK 123 million, driven by generally increased demand for our products, primarily in Industrial Solutions and Electrification & Renewables. With a strong order backlog and a flexible approach, we delivered positive adjusted operating profit of SEK 12 million during the quarter, compared with SEK 1 million in the year-earlier period.

Through increased ambitions in green hydrogen – a sub segment to Electrification & Renewables – we are accelerating our efforts in the business area, where Permascand has a great deal of experience in delivering hydrogen electrodes to the hydrogen market. During the quarter, our primary focus was on launching the largest innovation investment in the company’s history. By constructing a full-scale technology and innovation center and through investments in the company’s research team, Permascand will pursue advanced research and development to facilitate large-scale, cost-efficient production of green hydrogen for energy storage, where we hold a unique position. The plan is to launch the technology and innovation center in 2022. In total, we are planning to invest around SEK 300 million over the next three years, and our focus going forward will be to gather the resources and skills needed to develop the next generation of hydrogen electrodes and electrolyzers.

We see a major opportunity in the market for green hydrogen produced via electrolysis, a market in which Permascand has delivered electrodes for electrolysis for over 20 years. Permascand has its greatest potential in green hydrogen, and our long-term ambition is to position ourselves as one of the leading independent suppliers of catalytic coatings, electrodes and electrochemical cells in the field.

In Industrial Solutions, awareness is growing about the climate benefits generated by using dimensionally stable anodes (Permascand DSA® – catalytic coatings on a titanium substrate), which is driving demand in the segment. Our long experience and know-how means we can deliver successful concepts and smart technology adapted to each specific customer. We are now in dialogue with customers in Industrial Solutions regarding other environmental applications outside the segment, in which players such as Chemetry have several exciting projects in their pipelines where Permascand can play a key role in the value chain. One example is the letter of intent with Verdagy, a spin-out from Chemetry, which was signed in the second quarter and attributable to the Electrification & Renewables segment. The partnership with Verdagy builds further on the successful partnership between Permascand and Chemetry for the commercialization of electrochemical cells for Chemetry’s eShuttle® technology, and relates to joint development of a new electrochemical cell for the production of green hydrogen.

COVID-19 continued to impact our customers in Water Treatment during the quarter. Port and border closures and deferments granted by regulatory agencies as a result of the pandemic, in combination with historically high raw materials prices, are expected to continue to dampen growth in the business area over the short term. The need for systems that can efficiently purify ballast water remains, and we believe that market conditions beyond the pandemic remain basically unchanged. We have a strong order book in Water Treatment, and are looking forward to the deliveries ahead of us in the coming quarters.

Using a flexible approach, we have continued to adapt our operations and our working methods to the new reality. This will lead to continual productivity increases in many parts of our operations after COVID-19 as well. Despite a market performance that is difficult to assess from a short-term perspective, we are well positioned to capture additional market shares, strengthen our profitability and increase our lead over our competitors. Permascand is stronger than ever, and we look forward to restrictions being eased and to life returning to normal as soon as possible. I would like to take this opportunity to welcome all our new shareholders and to thank all our employees, suppliers and partners for their hard work during this highly eventful first half of 2021.

Exercise of overallotment option and end of stabilization period

ABG Sundal Collier AB ("ABG"), in its capacity as Joint Global Coordinator and stabilization manager, notifies that the overallotment option in connection with Permascand Top Holding AB's (publ) offering of shares prior to the listing on Nasdaq First North Premier Growth Market (the "Offering") has been partly exercised. A total of 2,107,900 shares were exercised of the overallotment option. The stabilisation period has now ended and no further stabilisation measures will be conducted.

As announced in connection with the Offering, ABG has had the option, acting as Joint Global Coordinator and stabilisation manager, to carry out transactions aimed at supporting the market price of the shares at levels above those which might otherwise have prevailed in the market. Stabilisation transactions could have been undertaken on Nasdaq First North Premier Growth Market, in the over-the-counter market or otherwise, at any time during the period from the date of commencement of trading in the shares on Nasdaq First North Premier Growth Market, 4 June 2021, and ending no later than 30 calendar days thereafter. However, ABG had no obligation to undertake any stabilisation measures. Transactions have not been permitted to be conducted at a price higher than set out in the Offering, i.e. SEK 34.

The Main Shareholder[1] of the Company granted ABG an over-allotment option which could have been utilised in whole or in part for 30 days from the first day of trading of the Company's shares on Nasdaq First North Premier Growth Market to be able to sell up to 2,229,094 shares corresponding to up to 15 percent of the total number of shares in the Offering to cover any over-allotment in connection with the Offering.

ABG now notifies that the over-allotment option has been exercised corresponding to 2,107,900 shares. Thus, the remaining part of the over-allotment option that was not exercised, corresponding to 121,194 shares, will be returned to the Main Shareholder.

The stabilisation period in the Offering has now ended and no further stabilisation transactions will be conducted. ABG announces, in its capacity as Joint Global Coordinator and stabilisation manager, that stabilisation measures have been undertaken in accordance with article 5(4) in the EU Market Abuse Regulation 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 as specified below.

The contact person at ABG is Erik Skog (tel: +46 8 566 29 471, e-mail: erik.skog@abgsc.se).

Stabilisation information:
Issuer: Permascand Top Holding AB (publ)
Securities: Ordinary shares (ISIN: SE0015962048)
Offering size: 14,860,627 shares
Offer price: 34 SEK
Ticker: PSCAND
Stabilisation manager: ABG Sundal Collier AB
Stabilisation transactions:
Date Quantity, shares Price (highest) Price (lowest) Price (volume weighted average) Currency Trading venue
4 June 2021 121,194 34.00 34.00 34.00 SEK Nasdaq First North Premier Growth Market (SSME)

[1] Norvestor VI, L.P.

Stabilisation notice

ABG Sundal Collier AB ("ABG"), in its capacity as Joint Global Coordinator, notifies that stabilisation measures have been undertaken in Permascand Top Holding AB:s (publ) (“Permascand” or the “Company”) shares traded on Nasdaq First North Premier Growth Market.

As announced in connection with the offering to acquire newly issued and existing shares in the Company and the listing of the Company’s shares on Nasdaq First North Premier Growth Market (the ”Offering”), ABG may, acting as Joint Global Coordinator and stabilisation manager, carry out transactions aimed at supporting the market price of the shares at levels above those which might otherwise prevail in the market.

Stabilisation transactions may be undertaken on Nasdaq First North Premier Growth Market in the over-the-counter market or otherwise, at any time during the period from the date of commencement of trading in the shares on Nasdaq First North Premier Growth Market, 4 June 2021, and ending no later than 30 calendar days thereafter. However, the Joint Global Coordinator has no obligation to undertake any stabilisation measures and there is no assurance that stabilisation measures will be undertaken. Under no circumstances will transactions be conducted at a price higher than the one set in the Offering, i.e. SEK 34.

The Main Shareholder of the Company have granted Joint Global Coordinator an over-allotment option which may be utilised in whole or in part for 30 days from the first day of trading of the Company's shares on Nasdaq First North Premier Growth Market to sell up to 2,229,094 shares corresponding to up to 15 percent of the total number of shares in the Offering, at a price corresponding to the price in the Offering, i.e. SEK 34 per share, to cover any over-allotment in connection with the Offering.

ABG has, in its capacity as stabilisation manager, notified that stabilisation measures have been undertaken in accordance with article 5(4) of the Market Abuse Regulation (EU) 596/2014 and the Commission Delegated Regulation (EU) 2016/1052 on Nasdaq First North Premier Growth Market, as specified below. The contact person at ABG is Erik Skog (tel: +46 8 566 27 471, e-mail: erik.skog@abgsc.se).

Stabilisation information:
Issuer: Permascand Top Holding AB (publ)
Securities: Ordinary shares (ISIN: SE0015962048)
Offering size: 14,860,627 shares
Over-allotment option: 2,229,094 shares
Offer price: 34 SEK
Ticker: PSCAND
Stabilisation manager: ABG Sundal Collier AB
Stabilisation transactions:
Date Quantity, shares Price (highest) Price (lowest) Price (volume weighted average) Curr-ency Trading venue
4 June 2021 121,194 34.00 34.00 34.00 SEK Nasdaq First North Growth Market

Disclaimer

The information contained in this section of this website contains information relating to an offer from Permascand Top Holding AB (the “Company“) to the public to subscribe for share in connection with the admission to trading of Permascand Top Holding AB’s shares on Nasdaq First North Premier Growth Market in Stockholm. This information may not be accessed by residents of certain countries based on applicable securities law regulations.

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WHOLLY OR PARTLY, IN THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS), ANY STATE OF THE UNITED STATES INCLUDING THE DISTRICT OF COLUMBIA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SWITZERLAND, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW.

This website and the information contained herein is not intended for, and may not be accessed by, or distributed or disseminated to, persons resident or physically present in the United States of America (including its territories and possessions), any state of the United States including the District of Columbia (the “United States“), Australia, Canada, Hong Kong, Japan, New Zealand, Singapore, Switzerland, South Africa, South Korea and do not constitute an offer to sell or the solicitation of an offer to purchase or acquire, any shares in the Company in any of the above mentioned jurisdictions or in any other jurisdiction in which such offer or solicitation would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. The shares in the Company referred to on this website have not been, and will not be, registered under the Securities Act of 1933, as amended (the “Securities Act“), and may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act.

All persons residing outside of the above mentioned jurisdictions who wish to access the documents contained on this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website, or require registration or approval for any acquisition of securities by them. The Company assumes no responsibility if there is a violation of applicable law and regulations by any person.

If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this website. Access to electronic versions of these materials is being made available on this website by the Company in good faith and for information purposes only.

By clicking “Confirm” you confirm and certify that: